PT-141 10mg
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide derived from Melanotan II. It acts at MC3R and MC4R in the central nervous system, which sets it apart from compounds that work through peripheral vasodilation. Supplied for laboratory research use only. Not for human or veterinary use.
A centrally acting melanocortin agonist.
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide derived from Melanotan II. It acts at MC3R and MC4R in the central nervous system, which sets it apart from compounds that work through peripheral vasodilation.
What the research shows
Studies have examined its mechanism through central melanocortin pathways rather than vascular effects, including its influence on dopaminergic and oxytocinergic systems.
Regulatory approval in 2019 brought a large clinical dataset on safety and pharmacokinetics, making it one of the better-characterised peptides for melanocortin research.
Why researchers choose Aevryn Labs
Every batch is tested at a leading Australian university, where HPLC and mass spectrometry confirm a purity of 99% or higher. No generic overseas certificates.
Explore the research library
